Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Diplomat Pharmacy Inc (DPLO)

Diplomat Pharmacy Inc (DPLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 304,004
  • Shares Outstanding, K 76,001
  • Annual Sales, $ 5,493 M
  • Annual Income, $ -302,270 K
  • 60-Month Beta 0.82
  • Price/Sales 0.06
  • Price/Cash Flow 0.87
  • Price/Book 2.31
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.54
  • Most Recent Earnings -2.35 on 11/12/19
  • Next Earnings Date 03/20/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.19
  • Number of Estimates 7
  • High Estimate -0.16
  • Low Estimate -0.22
  • Prior Year 0.14
  • Growth Rate Est. (year over year) -235.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.98 +0.50%
on 02/03/20
4.12 -2.91%
on 02/03/20
-0.09 (-2.20%)
since 01/07/20
3-Month
2.43 +64.61%
on 11/12/19
6.35 -37.01%
on 11/11/19
-2.04 (-33.77%)
since 11/07/19
52-Week
2.43 +64.61%
on 11/12/19
14.46 -72.34%
on 02/20/19
-9.63 (-70.65%)
since 02/07/19

Most Recent Stories

More News
AM Best Assigns Indicative Issue Credit Ratings to UnitedHealth Group Incorporated's New Shelf Registration

AM Best has assigned indicative Long-Term Issue Credit Ratings of "a-" to senior unsecured issues, "bbb+" to subordinated issues and "bbb" to preferred stock to the recently filed shelf registration of...

DPLO : 4.00 (+0.25%)
UNH : 304.17 (+0.46%)
Generac Holdings Set to Join S&P MidCap 400; Alexander & Baldwin and America's Car-Mart to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, February 13:

GNRC : 160.84 (+2.07%)
ALEX : 11.46 (-3.05%)
DPLO : 4.00 (+0.25%)
UNH : 304.17 (+0.46%)
CRMT : 94.85 (-0.33%)
CRCM : 15.00 (+0.07%)
IAC : 134.67 (+1.70%)
SPGI : 352.89 (+0.75%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) in connection...

DPLO : 4.00 (+0.25%)
UNH : 304.17 (+0.46%)
DIPLOMAT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of DPLO and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder law firm, has launched an investigation into whether the board members of Diplomat Pharmacy, Inc. (NYSE: DPLO) breached their fiduciary...

UNH : 304.17 (+0.46%)
DPLO : 4.00 (+0.25%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of DIPLOMAT PHARMACY, INC - DPLO

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Diplomat Pharmacy,...

UNH : 304.17 (+0.46%)
DPLO : 4.00 (+0.25%)
ArQule and Fate Therapeutics soar; Sanofi and Diplomat fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:

BMY : 59.42 (+1.30%)
FATE : 32.75 (+4.73%)
IFF : 124.51 (-1.14%)
TCBI : 33.83 (+1.84%)
DPLO : 4.00 (+0.25%)
Look for Shares of Diplomat Pharmac to Potentially Rebound after Yesterday's 31.93% Sell Off

Diplomat Pharmac (NYSE:DPLO) traded in a range yesterday that spanned from a low of $3.92 to a high of $3.98. Yesterday, the shares fell 31.9%, which took the trading range below the 3-day low of $5.32...

DPLO : 4.00 (+0.25%)
UnitedHealth plans bargain bid for Diplomat Pharmacy

UnitedHealth plans to acquire Diplomat Pharmacy at a steep discount about a month after the specialty drug provider said it may not be able to make its debt payments.

UNH : 304.17 (+0.46%)
DPLO : 4.00 (+0.25%)
Shares of Diplomat Pharmac Rank the Highest in Terms of Relative Performance in the Health Care Services Industry (DPLO , MD , LHCG , PINC , CVS )

Here are the top 5 stocks in the Health Care Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DPLO : 4.00 (+0.25%)
LHCG : 199.22 (+2.11%)
MD : 19.72 (-1.30%)
Diplomat Pharmac Up 43.6% Since SmarTrend Uptrend Call (DPLO)

SmarTrend identified an Uptrend for Diplomat Pharmac (NYSE:DPLO) on November 18th, 2019 at $3.84. In approximately 2 weeks, Diplomat Pharmac has returned 43.62% as of today's recent price of $5.52.

DPLO : 4.00 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade DPLO with:

Business Summary

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including...

See More

Key Turning Points

2nd Resistance Point 4.01
1st Resistance Point 4.01
Last Price 4.00
1st Support Level 4.00
2nd Support Level 3.99

See More

52-Week High 14.46
Fibonacci 61.8% 9.86
Fibonacci 50% 8.44
Fibonacci 38.2% 7.03
Last Price 4.00
52-Week Low 2.43

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar